Priorities for developing respiratory syncytial virus vaccines in different target populations

Science Translational Medicine
18 March 2020 Vol 12, Issue 535
https://stm.sciencemag.org/

 

Review
Priorities for developing respiratory syncytial virus vaccines in different target populations
By Simon B. Drysdale, Rachael S. Barr, Christine S. Rollier, Christopher A. Green, Andrew J. Pollard, Charles J. Sande
Science Translational Medicine18 Mar 2020 Restricted Access
About 38 candidate vaccines and monoclonal antibodies are in clinical development for treating respiratory syncytial virus in different populations.